Claritas HealthTech recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Claritas iPET image processing software.
Claritas iPET uses algorithm-based software that the Singapore-based company said enhances the quality of PET scans by denoising images, sharpening organ boundaries, and generating higher-resolution images.
Scans processed with the algorithm can also provide additional details by using an overlay of an MRI or CT image of the same region. The company touted that iPET can reduce scan times by up to 80% while yielding similar image quality as captured under standard duration.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
